ACD-A (Fenwal Inc.)
Welcome to the PulseAid listing for the ACD-A drug offered from Fenwal Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fenwal Inc. |
| NON-PROPRIETARY NAME: | Antiocoagulant Citrate Dextrose Solution, Formula A |
| SUBSTANCE NAME: | DEXTROSE MONOHYDRATE; SODIUM CITRATE; ANHYDROUS CITRIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-10-24 |
| END MARKETING DATE: | 0000-00-00 |
ACD-A HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACD-A from Fenwal Inc. |
| LABELER NAME: | Fenwal Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.45; 2.2; 730(g/100mL; g/100mL; mg/100mL) |
| START MARKETING DATE: | 2012-10-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0942-9005_bf4444ef-bff1-46c8-b11d-99091f14262d |
| PRODUCT NDC: | 0942-9005 |
| APPLICATION NUMBER: | BN160918 |
Other DEXTROSE MONOHYDRATE; SODIUM CITRATE; ANHYDROUS CITRIC ACID Pharmaceutical Manufacturers / Labelers:
